Table 4.

Utilities for the different health states in the model.

	Utility
PRUCALOPRIDE
Starting treatment (weeks 1–4)	0.786
Continuing treatment after 4 weeks (weeks 5–8)	0.813
Continuing treatment after 8 weeks (weeks 9–12)	0.813
Responders to prucalopride (> 12 weeks)	0.890
CONTINUED LAXATIVE TREATMENT
Starting treatment (weeks 1–4)	0.781
Continuing treatment after 4 weeks (weeks 5–8)	0.805
Continuing treatment after 8 weeks (weeks 9–12)	0.805
Responders to continued laxative treatment (> 12 weeks)	0.879
SWITCH
Starting treatment with a new treatment (weeks 1–12)	0.784
Responders to switch treatment (> 12 weeks)	0.879
Drop-out	0.784